Impact of crystalline and amorphous matrices on successful spray drying of siRNA polyplexes for inhalation of nano-in-microparticles.
Journal
Advanced therapeutics
ISSN: 2366-3987
Titre abrégé: Adv Ther (Weinh)
Pays: Germany
ID NLM: 101724632
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
entrez:
2
8
2021
pubmed:
3
8
2021
medline:
3
8
2021
Statut:
epublish
Résumé
To develop stable and inhalable dry powder formulations with long shelf life, we spray dried polyplexes consisting of siRNA and a polyethylenimine based block copolymer in presence of mannitol or trehalose. We investigated the effect of inlet (T-In) and outlet (T-Out) temperature on the recovery of siRNA as well as adsorption effects within the tubing material. Choosing a low abrasion silicon tubing prevented siRNA loss due to adsorption. Mannitol and trehalose formulations preserved siRNA integrity regardless of excipient concentration and temperature at T-Out below the siRNA melting temperature. Trehalose formulations allowed full siRNA recovery whereas mannitol formulations resulted in spray drying induced losses of ~20 % siRNA and of 50-60 % polymer. Mannitol formulations showed optimal aerodynamic characteristics as confirmed by next generation impaction analysis based upon siRNA content. All spray dried formulations resulted in GFP silencing comparable or better than freshly prepared polyplexes. To test if the observed results could be transferred, formulations of siRNA and transferrin-PEI conjugates were spray dried, characterized and used to transfect primary human T cells ex vivo. Results confirmed successful silencing of the Th2 transcription factor GATA3 in primary CD4
Identifiants
pubmed: 34337144
doi: 10.1002/adtp.202100073
pmc: PMC7611418
mid: EMS129617
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Research Council
ID : 637830
Pays : International
Références
Nanotechnology. 2017 Jun 2;28(22):224001
pubmed: 28488596
Recent Pat Drug Deliv Formul. 2015;9(3):225-36
pubmed: 26219931
J Control Release. 2011 Aug 10;153(3):262-8
pubmed: 21549166
Int J Pharm. 2018 Dec 1;552(1-2):67-75
pubmed: 30244146
Drugs. 2018 Oct;78(15):1625-1631
pubmed: 30251172
Mol Pharm. 2015 Mar 2;12(3):910-21
pubmed: 25599953
Sci Rep. 2016 May 11;6:25879
pubmed: 27165510
J Vet Sci. 2006 Dec;7(4):321-6
pubmed: 17106221
Pharm Res. 2013 Jun;30(6):1698-713
pubmed: 23568518
Int J Pharm. 2019 Mar 10;558:18-28
pubmed: 30597272
Pharm Res. 1999 Jul;16(7):1098-103
pubmed: 10450937
Adv Drug Deliv Rev. 2016 Sep 1;104:61-77
pubmed: 27352638
Science. 1984 Feb 17;223(4637):701-3
pubmed: 17841031
Small. 2018 Mar;14(12):e1701810
pubmed: 29430833
J Aerosol Med. 1991 Fall;4(3):151-6
pubmed: 10147676
Enzyme Microb Technol. 2013 Apr 10;52(4-5):211-7
pubmed: 23540921
Eur J Pharm Biopharm. 2005 Apr;59(3):565-73
pubmed: 15760738
J Control Release. 2016 May 10;229:120-129
pubmed: 27001893
Nucleic Acids Res. 2009 Feb;37(2):346-53
pubmed: 19042976
Eur J Pharm Biopharm. 2018 Aug;129:10-20
pubmed: 29777773
Eur J Pharm Biopharm. 2014 Jan;86(1):7-22
pubmed: 24007657
J Pharm Sci. 2018 Nov;107(11):2748-2754
pubmed: 30055225
Int J Pharm. 2019 Jul 20;566:32-39
pubmed: 31077763
J Pharm Sci. 1996 Nov;85(11):1137-41
pubmed: 8923318
J Pharm Sci. 2018 Oct;107(10):2538-2543
pubmed: 29890173
Mol Pharm. 2016 Jan 4;13(1):134-43
pubmed: 26641134
Eur J Pharm Sci. 2011 Sep 18;44(1-2):41-8
pubmed: 21699976
J Pharm Pharmacol. 2002 Aug;54(8):1033-9
pubmed: 12195816
J Clin Invest. 1999 Oct;104(8):985-93
pubmed: 10525032
Biomacromolecules. 2016 Jan 11;17(1):76-87
pubmed: 26636884
J Pharm Sci. 1999 Feb;88(2):199-208
pubmed: 9950639
J Control Release. 2018 Jun 10;279:99-113
pubmed: 29627404
Eur J Pharm Biopharm. 2019 Oct;143:61-69
pubmed: 31445157
Mol Diagn Ther. 2020 Feb;24(1):61-68
pubmed: 31792921
Eur J Pharm Biopharm. 2007 Jan;65(1):1-9
pubmed: 17034996
Eur J Pharm Biopharm. 2018 Jun;127:342-354
pubmed: 29522899
Annu Rev Physiol. 1992;54:579-99
pubmed: 1562184
J Pharm Sci. 2010 Feb;99(2):575-86
pubmed: 19774644
Sci Rep. 2016 Jul 08;6:28795
pubmed: 27387435
Adv Drug Deliv Rev. 2015 Oct 1;93:14-24
pubmed: 25982818
Adv Ther (Weinh). 2019 Jul;2(7):
pubmed: 31372493
Int J Pharm. 2012 May 30;428(1-2):121-4
pubmed: 22414387
Mol Diagn Ther. 2020 Feb;24(1):49-59
pubmed: 31701435
Protein Sci. 2009 Jan;18(1):24-36
pubmed: 19177348
Pharm Res. 2015 Jul;32(7):2419-27
pubmed: 25630820